Skip to Main Content

Advertisement

Skip Nav Destination

Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti–PD-1–based therapy

Blood Adv (2021) 5 (22): 4569–4574.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement